Patrick Holmes, Senior Director, Global Innovation Policy and Geopolitical Risk Lead, heads a team with responsibility for developing global health policy initiatives and evidence across a series of policy issues in support of Pfizer’s R&D-driven organization. These global initiatives are designed to drive positive impact with a focus on market-based R&D incentives, ensuring strong R&D ecosystems, value and innovation frameworks, sustainable patient-centric health systems, anticipating and responding to geopolitical developments, and antimicrobial resistance.
Patrick brings a range of experiences to his current role having worked across multiple areas of the biopharmaceutical business during his greater than 30-year career at Pfizer. Patrick joined Pfizer as a marketing associate in 1990 and held multiple positions of increasing responsibility in both US and global marketing spanning a range of therapeutic areas including hypertension, lipid lowering, arrhythmia, diabetes, erectile dysfunction, and allergies. Patrick then switched to a strategic planning role where he was responsible for evaluating new product opportunities and providing strategic input on behalf of the US commercial organization. He then led the Portfolio and Decision Analysis group, supporting strategic decisions and investment tradeoffs across Pfizer’s development portfolio. His last assignment prior to joining the policy team was Vice President, Strategy and Portfolio Support, providing comprehensive insights and identifying key emerging trends for Pfizer leaders.
Patrick has a BA in biology from Middlebury College and an MS in management from the Massachusetts Institute of Technology Sloan School of Management.